- Healthy male subjects and/or female subjects of non-childbearing potential between the
ages of 18 and 55 years.
- Evidence of a personally signed and dated informed consent document indicating that
the subject has been informed of all pertinent aspects of the study.
- Evidence or history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or
- Any condition possibly affecting drug absorption.